Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics

被引:46
作者
Mooij, Miriam G. [1 ,2 ]
Nies, Anne T. [3 ,4 ]
Knibbe, Catherijne A. J. [5 ,6 ]
Schaeffeler, Elke [3 ,4 ]
Tibboel, Dick [1 ,2 ]
Schwab, Matthias [3 ,7 ]
de Wildt, Saskia N. [1 ,2 ]
机构
[1] Erasmus MC Sophia Childrens Hosp, Intens Care, Room Sp 3458,Wytemaweg 80,POB 2060, NL-3000 CB Rotterdam, Netherlands
[2] Erasmus MC Sophia Childrens Hosp, Dept Pediat Surg, Room Sp 3458,Wytemaweg 80,POB 2060, NL-3000 CB Rotterdam, Netherlands
[3] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany
[4] Univ Tubingen, Tubingen, Germany
[5] Leiden Acad Ctr Res Pharmacol, Fac Sci, Leiden, Netherlands
[6] St Antonius Hosp, Hosp Pharm & Clin Pharmacol, Nieuwegein, Netherlands
[7] Univ Tubingen Hosp, Dept Clin Pharmacol, Tubingen, Germany
关键词
MESSENGER-RNA EXPRESSION; TACROLIMUS DOSING REQUIREMENTS; SINGLE-DOSE PHARMACOKINETICS; P-GLYCOPROTEIN EXPRESSION; FAMILIAL HYPERCHOLESTEROLEMIA; POPULATION PHARMACOKINETICS; INTERINDIVIDUAL VARIABILITY; GENETIC POLYMORPHISMS; METABOLIZING-ENZYMES; DOSAGE REQUIREMENTS;
D O I
10.1007/s40262-015-0328-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Membrane transporters play an essential role in the transport of endogenous and exogenous compounds, and consequently they mediate the uptake, distribution, and excretion of many drugs. The clinical relevance of transporters in drug disposition and their effect in adults have been shown in drug-drug interaction and pharmacogenomic studies. Little is known, however, about the ontogeny of human membrane transporters and their roles in pediatric pharmacotherapy. As they are involved in the transport of endogenous substrates, growth and development may be important determinants of their expression and activity. This review presents an overview of our current knowledge on human membrane transporters in pediatric drug disposition and effect. Existing pharmacokinetic and pharmacogenetic data on membrane substrate drugs frequently used in children are presented and related, where possible, to existing ex vivo data, providing a basis for developmental patterns for individual human membrane transporters. As data for individual transporters are currently still scarce, there is a striking information gap regarding the role of human membrane transporters in drug therapy in children.
引用
收藏
页码:507 / 524
页数:18
相关论文
共 50 条
  • [21] Proteomics of human liver membrane transporters: a focus on fetuses and newborn infants
    van Groen, Bianca D.
    van de Steeg, Evita
    Mooij, Miriam G.
    van Lipzig, Marola M. H.
    de Koning, Barbara A. E.
    Verdijk, Robert M.
    Wortelboer, Heleen M.
    Gaedigk, Roger
    Bi, Chengpeng
    Leeder, J. Steven
    van Schaik, Ron H. N.
    van Rosmalen, Joost
    Tibboel, Dick
    Vaes, Wouter H.
    de Wildt, Saskia N.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 124 : 217 - 227
  • [22] Expression and Regulation of Drug Transporters and Metabolizing Enzymes in the Human Gastrointestinal Tract
    Drozdzik, M.
    Oswald, S.
    CURRENT MEDICINAL CHEMISTRY, 2016, 23 (39) : 4468 - 4489
  • [23] Role of OATP transporters in the disposition of drugs
    Niemi, Mikko
    PHARMACOGENOMICS, 2007, 8 (07) : 787 - 802
  • [24] Phenotyping drug disposition in oncology
    Opdam, Frans L.
    Gelderblom, Hans
    Guchelaar, Henk-jan
    CANCER TREATMENT REVIEWS, 2012, 38 (06) : 715 - 725
  • [25] Transporters in Drug Development: International Transporter Consortium Update on Emerging Transporters of Clinical Importance
    Zamek-Gliszczynski, Maciej J.
    Sangha, Vishal
    Shen, Hong
    Feng, Bo
    Wittwer, Matthias B.
    Varma, Manthena V. S.
    Liang, Xiaomin
    Sugiyama, Yuichi
    Zhang, Lei
    Bendayan, Reina
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (03) : 485 - 500
  • [26] Drug Transporters at the Human Blood-Testis Barrier
    Hau, Raymond K.
    Wright, Stephen H.
    Cherrington, Nathan J.
    DRUG METABOLISM AND DISPOSITION, 2023, 51 (05) : 560 - 571
  • [27] Role of SLC22A1 polymorphic variants in drug disposition, therapeutic responses, and drug-drug interactions
    Arimany-Nardi, C.
    Koepsell, H.
    Pastor-Anglada, M.
    PHARMACOGENOMICS JOURNAL, 2015, 15 (06) : 473 - 487
  • [28] Drug transporter pharmacogenetics in nucleoside-based therapies
    Errasti-Murugarren, Ekaitz
    Pastor-Anglada, Marcal
    PHARMACOGENOMICS, 2010, 11 (06) : 809 - 841
  • [29] Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAART
    Bertrand, Julie
    Treluyer, Jean-Marc
    Panhard, Xaviere
    Tran, Agnes
    Auleley, Solange
    Rey, Elisabeth
    Salmon-Ceron, Dominique
    Duval, Xavier
    Mentre, France
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (07) : 667 - 678
  • [30] The Role of the Placenta in Fetal Exposure to Xenobiotics: Importance of Membrane Transporters and Human Models for Transfer Studies
    Prouillac, Caroline
    Lecoeur, Sylvaine
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (10) : 1623 - 1635